facebook page
Follow Me on Pinterest
twitter page
google plus page
rss feed

Recalled Product

Item detail and remedy information

Search Recalls or Browse by Category
Consumer Products (?)
Food & Health (?)
Vehicles (?)
Home > Recalled Products > Drugs > Contamination > Hospira 0.25% Bupivacaine HCl Injection & 0.75% Bupivacaine HCl Injection

Recall: Hospira 0.25% Bupivacaine HCl Injection & 0.75% Bupivacaine HCl Injection


On 2013-09-13, the FDA announced that Hospira is conducting a recall on 0.25% Bupivacaine HCl Injection & 0.75% Bupivacaine HCl Injection due to possible contamination with foreign matter. The recalled products were sold under the brand name(s) Hospira during an unspecified time period throughout the regions shown in the map below.

In recent months, there have been 6 drugs recalls due to potential contamination, including infants' drops, 10 percent, sulfite-free, 500ml and more. Additionally, there have been 30 drug and medical device recalls due to other health hazards as well as 62 food recalls.

Email Me About Recalls On:
Food  |  Drugs  |  Medical Devices  |  Pet Care Products  |  All of These

Hospira Logo
Note: Images may not be available for every version. Please review the detailed description below.

Company Contact Information:

Name: Hospira
Phone: 1-800-441-4100

Do you work for a company involved with this recall? Contact us to learn how you can control data, information and ads shown on this page.

Detailed Recall Information

Regions Where Sold: Nationwide

Product Description: Bupivacaine HCl Injections

Brand Name(s): Hospira

Reason for Recall: Particulates - Stainless Steel & Iron Oxide

Official Recall Date: 2013-09-13


Additional information provided by the

Hospira, Inc. (NYSE: HSP), announced today, on July 12, 2013, it initiated a voluntary nationwide recall to the user level for one lot of 0.25% Bupivacaine HCl Injection, USP (2.5 mg/mL), 30 mL Single-dose Vial (NDC 0409-1159-02). An expanded recall was issued on August 29, 2013 for one lot of 0.75% Bupivacaine HCl Injection, USP (7.5 mg/mL), 30 mL Single-dose Vial (NDC 0409-1165-02). Both recalls are due to confirmed customer reports of particulate floating and/or embedded in the glass vial. The particulate was identified as stainless steel ranging in size from 542 microns to 1700 microns in lot 18-136-DK (0.25% bupivacaine) and as iron oxide with an average size of 2000 microns in lot 23-338-DK (0.75% bupivacaine). To date, Hospira has not received reports of any adverse events associated with this issue for this lot. Read More.

More information may be available at

Latest Safety Recalls

Select image for details, including additional styles.




Do you have comments or questions about this recall? Share them here.
Note: The recalling companies may not be monitoring these comments; they should be directed toward the public. Community Guidelines apply.
comments powered by Disqus
Back to Top

Sources may include Food & Drug Administration (FDA), United States Department of Agriculture (USDA), Health Canada and companies involved with this or a related recall.